The Experience Matters. Let us show you why.
Contact us today.
What information should be examined in the study and work up of ADRs to determine whether the reaction is likely due to the drug or not.
Read MoreBart Cobert reviews the changes and updates happening with UK and EMA inspections.
Read MoreWe participate in safety reporting not only because it is required by law, but because we are HCPs whose first duty is always to protect the patient.
Read MoreBart Cobert addresses confusing areas in Drug Safety and Pharmacovigilance including Brexit, basic terminology, date formatting and others.
Read MorePharmacovigilance expert Bart Cobert examines the issues associated with language translation in PV and drug safety.
Read MoreBart Cobert examines the importance of, and differences between Data Monitoring Committees (DMCs) & Safety Assessment Committees (SACs).
Read MoreBart Cobert reviews the key requirements for the US-EU Privacy Shield, including implications for US Firms, Pharma Companies, and Drug Safety & Pharmacovigilance
Read MoreExploring the role of the Medical Monitor in the clinical research process.
Read MoreBart Cobert reviews the HIPAA and current EU data privacy system and their impacts on drug safety and PV.
Read MoreAs an industry leader in business process outsourcing, HCL Technologies delivers global, multi-channel engagement solutions. The Experience Matters. Let us show you why.
Contact UsPlease note: we are currently updating our website which will be live shortly.